Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Client, organization or corporation number: 15599
Share this search Create an alert
Start over
Modify criteria

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (38)
Results: 1-38 | Export
  1. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Mark Vineis, Country President
    Registration: 38 of 38 (2024-05-01 to present)
    Posted: 2024-05-22
    Subject matter details: 9
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  2. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Mark Vineis, Country President
    Registration: 37 of 38 (2024-01-01 to 2024-05-01)
    Posted: 2024-02-07
    Subject matter details: 9
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  3. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Pedro Ferreira, Country President
    Registration: 36 of 38 (2023-11-01 to 2024-01-01)
    Posted: 2023-12-07
    Subject matter details: 9
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1
  4. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Pedro Ferreira, Country President
    Registration: 35 of 38 (2023-10-01 to 2023-11-01)
    Posted: 2023-10-16
    Subject matter details: 9
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1
  5. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Andrea Marazzi, Country President
    Registration: 34 of 38 (2023-01-13 to 2023-10-01)
    Posted: 2023-01-13
    Subject matter details: 9
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1
  6. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Andrea Marazzi, Country President
    Registration: 33 of 38 (2022-10-05 to 2023-01-13)
    Posted: 2022-10-05
    Subject matter details: 11
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  7. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Andrea Marazzi, Country President
    Registration: 32 of 38 (2022-06-01 to 2022-10-05)
    Posted: 2022-06-16
    Subject matter details: 11
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  8. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Christian Macher, Country President & Oncology General Manager Canada
    Registration: 31 of 38 (2021-12-16 to 2022-06-01)
    Posted: 2021-12-16
    Subject matter details: 11
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  9. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Christian Macher, Country President & Oncology General Manager Canada
    Registration: 30 of 38 (2021-05-03 to 2021-12-16)
    Posted: 2021-05-03
    Subject matter details: 11
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  10. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Christian Macher, Country President & Oncology General Manager Canada
    Registration: 29 of 38 (2020-09-14 to 2021-05-03)
    Posted: 2020-09-14
    Subject matter details: 11
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  11. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Christian Macher, Country President & Oncology General Manager Canada
    Registration: 28 of 38 (2020-06-04 to 2020-09-14)
    Posted: 2020-06-05
    Subject matter details: 11
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  12. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Christian Macher, Country President & Oncology General Manager Canada
    Registration: 27 of 38 (2020-02-14 to 2020-06-04)
    Posted: 2020-02-14
    Subject matter details: 11
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  13. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Christian Macher, Country President & Oncology General Manager Canada
    Registration: 26 of 38 (2019-11-29 to 2020-02-14)
    Posted: 2019-11-29
    Subject matter details: 11
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  14. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Christian Macher, Country President & Oncology General Manager Canada
    Registration: 25 of 38 (2019-05-01 to 2019-11-29)
    Posted: 2019-06-20
    Subject matter details: 11
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  15. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Thea Discepola, Interim President
    Registration: 24 of 38 (2019-03-01 to 2019-05-01)
    Posted: 2019-04-12
    Subject matter details: 11
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  16. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Janice Murray, President
    Registration: 23 of 38 (2018-06-11 to 2019-03-01)
    Posted: 2018-06-12
    Subject matter details: 11
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  17. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Janice Murray, President
    Registration: 22 of 38 (2018-05-14 to 2018-06-11)
    Posted: 2018-05-17
    Subject matter details: 11
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  18. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Janice Murray, President
    Registration: 21 of 38 (2018-03-20 to 2018-05-14)
    Posted: 2018-03-21
    Subject matter details: 13
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  19. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Janice Murray, President
    Registration: 20 of 38 (2017-10-18 to 2018-03-20)
    Posted: 2017-10-19
    Subject matter details: 12
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  20. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Janice Murray, President
    Registration: 19 of 38 (2017-05-01 to 2017-10-18)
    Posted: 2017-05-30
    Subject matter details: 12
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  21. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Timothy Maloney, President
    Registration: 18 of 38 (2017-03-21 to 2017-05-01)
    Posted: 2017-03-21
    Subject matter details: 11
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  22. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Timothy Maloney, President
    Registration: 17 of 38 (2016-10-19 to 2017-03-21)
    Posted: 2016-10-21
    Subject matter details: 11
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  23. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Timothy Maloney, President
    Registration: 16 of 38 (2016-05-27 to 2016-10-19)
    Posted: 2016-05-27
    Subject matter details: 11
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  24. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Timothy Maloney, President
    Registration: 15 of 38 (2016-01-12 to 2016-05-27)
    Posted: 2016-01-13
    Subject matter details: 10
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  25. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Timothy Maloney, President
    Registration: 14 of 38 (2015-08-18 to 2016-01-12)
    Posted: 2015-08-18
    Subject matter details: 12
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  26. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Timothy Maloney, President
    Registration: 13 of 38 (2015-04-09 to 2015-08-18)
    Posted: 2015-04-09
    Subject matter details: 11
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  27. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Timothy Maloney, President
    Registration: 12 of 38 (2014-11-17 to 2015-04-09)
    Posted: 2014-11-19
    Subject matter details: 10
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  28. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Timothy Maloney, President
    Registration: 11 of 38 (2014-04-01 to 2014-11-17)
    Posted: 2014-07-07
    Subject matter details: 10
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  29. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Riad Sherif, President
    Registration: 10 of 38 (2014-02-21 to 2014-04-01)
    Posted: 2014-02-24
    Subject matter details: 10
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  30. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Riad Sherif, President
    Registration: 9 of 38 (2013-10-03 to 2014-02-21)
    Posted: 2013-10-03
    Subject matter details: 9
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  31. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Riad Sherif, President
    Registration: 8 of 38 (2013-08-15 to 2013-10-03)
    Posted: 2013-08-15
    Subject matter details: 9
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  32. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Riad Sherif, President
    Registration: 7 of 38 (2013-03-04 to 2013-08-15)
    Posted: 2013-03-04
    Subject matter details: 9
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  33. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Riad Sherif, President
    Registration: 6 of 38 (2012-09-20 to 2013-03-02)
    Posted: 2012-09-21
    Subject matter details: 9
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  34. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Riad Sherif, President
    Registration: 5 of 38 (2012-04-12 to 2012-09-20)
    Posted: 2012-04-13
    Subject matter details: 9
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  35. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Riad Sherif, President
    Registration: 4 of 38 (2011-12-02 to 2012-04-12)
    Posted: 2012-04-10
    Subject matter details: 9
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  36. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: Tom Rossi, President
    Registration: 3 of 38 (2010-01-04 to 2011-02-02)
    Posted: 2010-08-16
    Subject matter details: 9
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1
  37. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: David Meek, President
    Registration: 2 of 38 (2008-02-12 to 2008-06-30)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 5
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 6
  38. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Responsible officer: David Meek, President
    Registration: 1 of 38 (2007-07-13 to 2008-02-12)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 5
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 3
Date Modified: